Biomarin Pharmaceutical Stock Price. Everything You Need To Know About The Biomarin Pharmaceutical Stock!
BioMarin Pharmaceutical Inc. is a biotechnology company focused on developing and commercializing therapies that address the root cause of genetic conditions. The company’s portfolio includes seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases.
BioMarin’s commercial products, including Vimizim, Naglazyme, Kuvan, Palynziq, Brineura, Roctavian, and Voxzogo, offer therapies for a range of genetic conditions. The Roctavian, in particular, is an adeno associated virus (AAV5) vector drug development candidate designed to restore factor VIII plasma concentrations in patients with severe hemophilia A.
Beyond its commercial products, BioMarin has several clinical development programs in progress, such as BMN 331, an AAV5 mediated gene therapy for people living with Hereditary Angioedema (HAE), and BMN 255, a small-molecule therapy designed to treat hyperoxaluria in chronic liver disease.
For investors interested in tracking the performance of BioMarin Pharmaceutical Inc., monitoring the stock price today and premarket activity can provide valuable insights. Additionally, the company’s market cap and shares may also be important factors to consider when evaluating its overall performance in the stock market.
Biomarin Pharmaceutical Stock Price. Everything You Need To Know About The Biomarin Pharmaceutical Stock! performance
- Employees 3082
- Company HQ Novato
- Website https://www.biomarin.com/
- BMRN Asset Type Common Stock
- BMRN Market Capitalization 15.7B
- Earnings Per Share 1.06
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0.722
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to expand your investment portfolio? Look no further than Biomarin Pharmaceutical! As a leading biopharmaceutical company, Biomarin develops and commercializes innovative therapies for rare genetic diseases. With a strong track record and a diverse pipeline of potential breakthrough treatments, Biomarin presents a promising investment opportunity. But how can you invest in Biomarin Pharmaceutical from Malaysia, Thailand, Indonesia, or Vietnam? At Zorion, we make it easy for retail investors to access global stocks like Biomarin. Our investment platform offers a seamless and user-friendly experience, enabling you to invest in real US stocks and Pre-IPO companies effortlessly. To make informed investment decisions, Zorion provides investment insights and recommendations specifically tailored for retail investors in Malaysia, Thailand, Indonesia, and Vietnam. Our goal is to empower you with the knowledge and resources needed to navigate the complex world of investing. Whether you’re a seasoned investor or just starting your investment journey, Zorion offers educational materials and resources to further enhance your investment knowledge. We believe that education is key to successful investing, and we are committed to providing you with the tools you need to make informed decisions. Don’t miss out on the potential growth opportunities Biomarin Pharmaceutical and other global stocks can offer. Join Zorion today and start investing confidently from Malaysia, Thailand, Indonesia, or Vietnam.
